A
Andrea Angheben
Researcher at Mario Negri Institute for Pharmacological Research
Publications - 134
Citations - 4778
Andrea Angheben is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Medicine & Malaria. The author has an hindex of 33, co-authored 119 publications receiving 3792 citations.
Papers
More filters
Journal ArticleDOI
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Carlo Salvarani,Giovanni Dolci,Marco Massari,Domenico Franco Merlo,Silvio Cavuto,Luisa Savoldi,Paolo Bruzzi,Fabrizio Boni,Luca Braglia,Caterina Turrà,Pier Ferruccio Ballerini,Roberto Sciascia,Lorenzo Zammarchi,Ombretta Para,Pier Giorgio Scotton,Walter O Inojosa,Viviana Ravagnani,Nicola Duccio Salerno,Pier Paolo Sainaghi,Alessandro Brignone,Mauro Codeluppi,Elisabetta Teopompi,Maurizio Milesi,Perla Bertomoro,Norbiato Claudio,Mario Salio,Marco Falcone,Marco Falcone,Giovanni Cenderello,Lorenzo Donghi,Valerio Del Bono,Paolo Luigi Colombelli,Andrea Angheben,Angelina Passaro,Giovanni Secondo,Renato Pascale,Ilaria Piazza,Nicola Facciolongo,Massimo Costantini +38 more
TL;DR: This randomized clinical trial of hospitalized adult patients with COVID-19 pneumonia and Pao2/Fio2 ratio between 200 and 300 mm Hg who received tocilizumab found no benefit on disease progression was observed compared with standard care, and further blinded, placebo-controlled randomized clinical trials are needed.
Journal ArticleDOI
The role of rapid diagnostic tests in managing malaria
TL;DR: A new clinical trial in Zanzibar comparing symptom-based clinical diagnosis of malaria versus clinical diagnosis plus rapid diagnostic tests is discussed.
Journal ArticleDOI
Severe strongyloidiasis: a systematic review of case reports
Dora Buonfrate,Ana Requena-Méndez,Andrea Angheben,Jose Muñoz,Federico Gobbi,Jef Van den Ende,Zeno Bisoffi +6 more
TL;DR: Proper screening (which must include serology) is mandatory in high - risk patients, for instance candidates to immunosuppressive medications, currently or previously living in endemic countries.
Journal ArticleDOI
Chagas disease in European countries: the challenge of a surveillance system
Luca Basile,J M Jansa,Yves Carlier,D D Salamanca,Andrea Angheben,Alessandro Bartoloni,Jorge Seixas,T. van Gool,Carmen Cañavate,María Flores-Chávez,Yves-Laurent Julien Jackson,Peter L. Chiodini,Pedro Albajar-Viñas +12 more
TL;DR: Urgent measures need to be taken to detect new cases of congenital transmission and take care of the existing cases with a focus on migrants without legal residency permit and potential difficulty accessing care.
Journal ArticleDOI
Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection
Zeno Bisoffi,Dora Buonfrate,Marco Sequi,Rojelio Mejia,Rubén O. Cimino,Alejandro J. Krolewiecki,Marco Albonico,Maria Gobbo,Stefania Bonafini,Andrea Angheben,Ana Requena-Méndez,Jose Muñoz,Thomas B. Nutman +12 more
TL;DR: NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection and IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies and inclusion in clinical trials.